Pulmonx Reports Mixed Q4 Results, Flat 2026 Guidance, Secures $60M Debt Facility

summarizeSummary

Pulmonx reported Q4 2025 financial results, issued flat 2026 revenue guidance, and announced a significant $60 million debt refinancing and cost restructuring initiative.

check_boxKey Events

• Mixed Q4 and Full Year 2025 Financial Results

  Worldwide revenue for Q4 2025 decreased 5% year-over-year to $22.6 million, while full year 2025 worldwide revenue increased 8% to $90.5 million. The company reported a net loss of $10.4 million for Q4 2025 and $54.0 million for the full year 2025.

• Flat Full Year 2026 Revenue Guidance

  Pulmonx expects full year 2026 revenue to be in the range of $90 million to $92 million, indicating minimal growth from 2025. Gross margin is projected at approximately 75%.

• Significant Debt Refinancing Secured

  The company refinanced its existing debt, securing up to $60 million in committed capital under a new 5-year interest-only credit facility that extends debt maturity to 2031. This provides substantial liquidity relative to the company's market cap.

• Cost Restructuring Initiative Underway

  Pulmonx executed a cost restructuring initiative aimed at reducing operating expenses while maintaining key commercial and clinical investments, with total operating expenses for 2026 expected between $113 million and $115 million.

auto_awesomeAnalysis

Pulmonx Corporation reported a mixed financial performance with a decline in Q4 2025 revenue and flat revenue guidance for 2026, indicating ongoing growth challenges. However, the company significantly strengthened its balance sheet by securing a new $60 million credit facility, extending debt maturity to 2031, and implementing cost restructuring. For a company with a market capitalization of approximately $59 million, this debt refinancing is a critical liquidity event that provides substantial financial runway and de-risks near-term operations, despite the continued net losses. Investors should monitor the company's ability to reaccelerate commercial growth and achieve profitability with this extended financial flexibility.